While theyre fundamentally similar medications, they differ slightly in their mechanism of action: Wegovy (semaglutide) is a GLP-1 agonist Zepbound (tirzepatide) is a dual agonist: GLP-1 + a glucose-dependent insulinotropic polypeptide (GIP) Both semaglutide and tirzepatide affect the hypothalamus and the hedonic eating centers, the brains center of appetite and cravings
Glucagon-like peptide-1 preserves non-alcoholic fatty liver disease through inhibition of the endoplasmic reticulum stressassociated pathway
Every two weeks, a clinician assesses progress and determines whether the dose should stay the same, increase slightly, or decrease based on how the body responds
Skin does not shrink at the same rate as fat loss
Inadequate protein intake during rapid weight loss causes muscle loss
Regular check-ins with your healthcare provider are crucial to make sure youre on the right track and taking the correct dosage, said Bruno